Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K973448
    Date Cleared
    1998-09-17

    (371 days)

    Product Code
    Regulation Number
    866.3780
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    ACCESS TOXOPLASMA IGM REAGENTS ON THE ACCESS IMMUNOASSAY ANALYZER, MODELS 34460, 34465, 34469

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Access® Toxo IgM assay is a paramagnetic-particle chemiluminescent immunoassay for the qualitative detection of anti-Toxoplasma IgM in adult human serum, using the Access® Immunoassay System. The Access® Toxo IgM assay is presumptive for the diagnosis of acute, recent, or reactivated Toxoplasma gondii infections in males and pregnant or non-pregnant females. It is recommended this assay be performed in conjunction with an anti-Toxoplasma gondii IgG antibody assay.

    Device Description

    The Access® Toxo IgM assay is a paramagnetic-particle chemiluminescent immunoassay for the qualitative detection of anti-Toxoplasma IgM in adult human serum, using the Access® Immunoassay System. The Access® Toxo IgM assay is presumptive for the diagnosis of acute, recent, or reactivated Toxoplasma gondii infections in males and pregnant or nonpregnant females. It is recommended this assay be performed in conjunction with an anti-Toxoplasma gondii IgG antibody assay.

    AI/ML Overview

    The acceptance criteria for the Beckman Instruments ACCESS® Toxo IgM assay and its reported performance are described below based on the provided document.

    1. Table of Acceptance Criteria and Reported Device Performance

    MetricAcceptance CriteriaReported Device Performance
    Sensitivity (vs. predicate)Not explicitly stated as a numerical criterion, but the context implies substantial equivalence to the predicate device, Platelia® Toxo IgM.96%
    Specificity (vs. predicate)Not explicitly stated as a numerical criterion, but the context implies substantial equivalence to the predicate device, Platelia® Toxo IgM.99.7%
    Resolved SensitivityNot explicitly stated as a numerical criterion.96% (after discrepancy analysis)
    Resolved SpecificityNot explicitly stated as a numerical criterion.99.7% (after discrepancy analysis)
    Specificity (in prospective population with 1.25% prevalence)Not explicitly stated as a numerical criterion, but relative to a consensus result in a specific population type.99.2%
    Intra-assay Precision (CV)Not explicitly stated as a numerical criterion, but typically
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1